Quidditas Therapeutics
Montlhéry
About Quidditas Therapeutics
Quidditas Therapeutics develops an alternative technology which permits an absolute genetic recombination.
Company Facts
- Operating status: Active
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.9M
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: quidditastherapeutics.com
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/quidditas-therapeutics-111448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.